Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of CBD (Epidiolex) in Idiopathic Generalized Epilepsy With Typical Absence Seizures

NCT04899050 is registered in ClinicalTrials.gov with University of South Florida as lead sponsor.

NCT NCT04899050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04899050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of CBD (Epidiolex) in Idiopathic Generalized Epilepsy With Typical Absence Seizures
Lead sponsor
University of South Florida
Phase
Phase 4
Overall status
Completed
Start date
July 30, 2021
Completion date
May 27, 2023
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

study the efficacy of epidiolex for typical absence seizures